2007
DOI: 10.1111/j.1365-2036.2006.03233.x
|View full text |Cite
|
Sign up to set email alerts
|

The Short‐Form Leeds Dyspepsia Questionnaire validation study

Abstract: SUMMARY BackgroundAssessment of symptoms should be the primary outcome measure in dyspepsia clinical trials. This requires a reliable, valid and responsive questionnaire that measures the frequency and severity of dyspepsia. The Leeds Dyspepsia Questionnaire fulfils these characteristics, but is long and was not designed for self-completion, so a shorter questionnaire was developed (the Short-Form Leeds Dyspepsia Questionnaire).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
82
0
1

Year Published

2010
2010
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 82 publications
(85 citation statements)
references
References 37 publications
(46 reference statements)
2
82
0
1
Order By: Relevance
“…Five symptoms including epigastric pain, postprandial distention, indigestion, heartburn and nausea were graded for severity on a five-point Likert scale from very mild to very severe: no symptoms (0 point), mild symptoms without influence on regular work (1 point), mild symptoms with influence on regular work (2 points), moderate symptoms (3 points), severe symptoms (4 points) and extremely severe symptoms (5 points). SF-LDQ is a validated and reliable tool to assess the dyspeptic symptoms of patients with FD with higher scores indicating worse dyspeptic outcomes [15,16].…”
Section: Methodsmentioning
confidence: 99%
“…Five symptoms including epigastric pain, postprandial distention, indigestion, heartburn and nausea were graded for severity on a five-point Likert scale from very mild to very severe: no symptoms (0 point), mild symptoms without influence on regular work (1 point), mild symptoms with influence on regular work (2 points), moderate symptoms (3 points), severe symptoms (4 points) and extremely severe symptoms (5 points). SF-LDQ is a validated and reliable tool to assess the dyspeptic symptoms of patients with FD with higher scores indicating worse dyspeptic outcomes [15,16].…”
Section: Methodsmentioning
confidence: 99%
“…While the SFLDQ only assesses a limited range of dyspeptic symptoms, and does not include assessment of postprandial symptoms, which have been highly prevalent in Western studies, correlation between the SFLDQ and other lengthier tools that include such symptoms has been high in published validation studies. [8,9] As a symptom complex, uninvestigated dyspepsia does not have a single underlying pathological mechanism. Putative contributing factors include Helicobacter pylori infection, gastric acid and gastric dysmotility.…”
Section: Discussionmentioning
confidence: 99%
“…The developers of the SFLDQ have defined a score of 0 as 'no dyspepsia' , a score of 1 4 as 'very mild dyspepsia' , a score of 5 8 as 'mild dyspepsia' , a score of 9 15 as 'moderate dyspepsia' and a score >15 as indicative of 'severe dyspepsia' . [8] In the design of the study, we planned to analyse these results categorically but also dichotomously, with those in the 'no dyspepsia' and 'very mild dyspepsia' groups defined as nondyspeptic (i.e. those with an SFLDQ score of <5).…”
Section: The Short-form Leeds Dyspepsia Questionnairementioning
confidence: 99%
“…The severity of upper gastrointestinal symptoms was assessed using the Short-Form Leeds Dyspepsia Questionnaire (14). Medication history was recorded.…”
Section: Study Day 1: Clinical Measurementsmentioning
confidence: 99%